Join
Live feed
·
PRReleasevia Quantisnow
InspireMD Inc. logo

InspireMD Announces 30-Day Results from the CGUARDIANS II Clinical Trial of the CGuard Prime 80 cm Implant for Use in TCAR Procedures

ByQuantisnow·Wall Street's wire, on your screen.
NSPR· InspireMD Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NSPR (InspireMD Inc.) and more on Quantisnow.